Under growing pressure resulting from staff shortages, overburdened funding, an ageing population and most recently a global pandemic, healthcare systems across the world are supporting the drive towards self-administration of injectable medication for patients with chronic diseases. The number of people worldwide aged 60 and over is projected to nearly double by 2050. By shifting the administration of certain therapies towards the home and away from the traditional clinical setting, hospitals are exporting a lower-risk medical procedure. George I’ons at Owen Mumford Pharmaceutical Services explores how this helps to manage occupancy pressures within their facilities and encourages patients to be more involved in their own medication regime.